These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 29909338

  • 1. N-phenylsulfonyl-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines.
    Li N, Xin WY, Yao BR, Cong W, Wang CH, Hou GG.
    Eur J Med Chem; 2018 Jul 15; 155():531-544. PubMed ID: 29909338
    [Abstract] [Full Text] [Related]

  • 2. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.
    Cong W, Sun Y, Sun YF, Yan WB, Zhang YL, Gao ZF, Wang CH, Hou GG, Zhang JJ.
    J Enzyme Inhib Med Chem; 2021 Dec 15; 36(1):1622-1631. PubMed ID: 34284695
    [Abstract] [Full Text] [Related]

  • 3. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation.
    Yao BR, Sun Y, Chen SL, Suo HD, Zhang YL, Wei H, Wang CH, Zhao F, Cong W, Xin WY, Hou GG.
    Eur J Med Chem; 2019 Apr 01; 167():187-199. PubMed ID: 30771605
    [Abstract] [Full Text] [Related]

  • 4. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo.
    Li N, Xin WY, Yao BR, Wang CH, Cong W, Zhao F, Li HJ, Hou Y, Meng QG, Hou GG.
    Eur J Med Chem; 2018 Mar 10; 147():21-33. PubMed ID: 29421568
    [Abstract] [Full Text] [Related]

  • 5. Discovery of novel NF-кB inhibitor based on scaffold hopping: 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine.
    Sun Y, Gao ZF, Yan WB, Yao BR, Xin WY, Wang CH, Meng QG, Hou GG.
    Eur J Med Chem; 2020 Jul 15; 198():112366. PubMed ID: 32371335
    [Abstract] [Full Text] [Related]

  • 6. Anti-Inflammatory Effect of Novel 7-Substituted Coumarin Derivatives through Inhibition of NF-κB Signaling Pathway.
    Mu C, Wu M, Li Z.
    Chem Biodivers; 2019 Mar 15; 16(3):e1800559. PubMed ID: 30556357
    [Abstract] [Full Text] [Related]

  • 7. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation.
    Su CM, Hou GG, Wang CH, Zhang HQ, Yang C, Liu M, Hou Y.
    J Enzyme Inhib Med Chem; 2019 Dec 15; 34(1):1287-1297. PubMed ID: 31288582
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
    Olivera A, Moore TW, Hu F, Brown AP, Sun A, Liotta DC, Snyder JP, Yoon Y, Shim H, Marcus AI, Miller AH, Pace TW.
    Int Immunopharmacol; 2012 Feb 15; 12(2):368-77. PubMed ID: 22197802
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rational design, synthesis and in vitro evaluation of novel exo-methylene butyrolactone salicyloylamide as NF-κB inhibitor.
    Sidthipong K, Ma J, Yu WL, Wang YF, Kobayashi S, Kishino S, Koide N, Yokochi T, Kato K, Okada S, Umezawa K.
    Bioorg Med Chem Lett; 2017 Feb 01; 27(3):562-566. PubMed ID: 28003138
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rosmarinic acid sensitizes cell death through suppression of TNF-alpha-induced NF-kappaB activation and ROS generation in human leukemia U937 cells.
    Moon DO, Kim MO, Lee JD, Choi YH, Kim GY.
    Cancer Lett; 2010 Feb 28; 288(2):183-91. PubMed ID: 19619938
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, docking and evaluation of in vitro anti-inflammatory activity of novel morpholine capped β-lactam derivatives.
    Heiran R, Sepehri S, Jarrahpour A, Digiorgio C, Douafer H, Brunel JM, Gholami A, Riazimontazer E, Turos E.
    Bioorg Chem; 2020 Sep 28; 102():104091. PubMed ID: 32717692
    [Abstract] [Full Text] [Related]

  • 15. Nickel(II) complex of polyhydroxybenzaldehyde N4-thiosemicarbazone exhibits anti-inflammatory activity by inhibiting NF-κB transactivation.
    Shawish HB, Wong WY, Wong YL, Loh SW, Looi CY, Hassandarvish P, Phan AY, Wong WF, Wang H, Paterson IC, Ea CK, Mustafa MR, Maah MJ.
    PLoS One; 2014 Sep 28; 9(6):e100933. PubMed ID: 24977407
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
    Choi M, Jo H, Park HJ, Sateesh Kumar A, Lee J, Yun J, Kim Y, Han SB, Jung JK, Cho J, Lee K, Kwak JH, Lee H.
    Bioorg Med Chem Lett; 2015 Jun 15; 25(12):2545-9. PubMed ID: 25953156
    [Abstract] [Full Text] [Related]

  • 17. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
    Tse AK, Wan CK, Shen XL, Yang M, Fong WF.
    Biochem Pharmacol; 2005 Nov 15; 70(10):1443-57. PubMed ID: 16181613
    [Abstract] [Full Text] [Related]

  • 18. Design and Discovery of Some Novel Chalcones as Antioxidant and Anti-Inflammatory Agents via Attenuating NF-κB.
    Chu J, Guo CL.
    Arch Pharm (Weinheim); 2016 Jan 15; 349(1):63-70. PubMed ID: 26660296
    [Abstract] [Full Text] [Related]

  • 19. Discovery and optimization of tetrahydropyrido[4,3-d]pyrimidine derivatives as novel ATX and EGFR dual inhibitors.
    Jing T, Miao X, Jiang F, Guo M, Xing L, Zhang J, Zuo D, Lei H, Zhai X.
    Bioorg Med Chem; 2018 May 01; 26(8):1784-1796. PubMed ID: 29496411
    [Abstract] [Full Text] [Related]

  • 20. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation.
    Zhang L, Chen Q, Hou G, Zhao W, Hou Y.
    J Enzyme Inhib Med Chem; 2019 Dec 01; 34(1):264-271. PubMed ID: 30734613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.